|
1
|
Tindle R and Frazer I: Human papilloma
virus injection, genital warts and cervical cancer: prospects for
prophylactic and therapeutic vaccines. Exp Opin Invest Drugs.
4:7831995. View Article : Google Scholar
|
|
2
|
Giannini SL, Al-Saleh W, Piron H, et al:
Cytokine expression in squamous intraepithelial lesions of the
uterine cervix: implications for the generation of local
immunosuppression. Clin Exp Immunol. 113:183–189. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ho GY, Bierman R, Beardsley L, Chang CJ
and Burk RD: Natural history of cervicovaginal papillomavirus
infection in young women. N Engl J Med. 338:423–428. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mocellin S, Panelli MC, Wang E, Nagorsen D
and Marincola FM: The dual role of IL-10. Trends Immunol. 24:36–43.
2003. View Article : Google Scholar
|
|
5
|
Mocellin S, Marincola FM and Young HA:
Interleukin-10 and the immune response against cancer: a
counterpoint. J Leukoc Biol. 78:1043–1051. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mocellin S, Wang E and Marincola FM:
Cytokines and immune response in the tumor microenvironment. J
Immunother. 24:392–407. 2001. View Article : Google Scholar
|
|
7
|
Stanilov N, Miteva L, Deliysky T, Jovchev
J and Stanilova S: Advanced colorectal cancer is associated with
enhanced IL-23 and IL-10 serum levels. Lab Med. 41:159–163. 2010.
View Article : Google Scholar
|
|
8
|
Caruso C, Lio D, Cavallone L and
Franceschi C: Aging, longevity, inflammation, and cancer. Ann NY
Acad Sci. 1028:1–13. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Howell WM and Rose-Zerilli MJ:
Interleukin-10 polymorphisms, cancer susceptibility and prognosis.
Fam Cancer. 5:143–149. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kundu N and Fulton AM: Interleukin-10
inhibits tumor metastasis, downregulates MHC class I, and enhances
NK lysis. Cell Immunol. 180:55–61. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang S, Xie K, Bucana CD, Ullrich SE and
Bar-Eli M: Interleukin 10 suppresses tumor growth and metastasis of
human melanoma cells: potential inhibition of angiogenesis. Clin
Cancer Res. 2:1969–1979. 1996.PubMed/NCBI
|
|
12
|
Stearns ME, Garcia FU, Fudge K, Rhim J and
Wang M: Role of interleukin 10 and transforming growth factor beta1
in the angiogenesis and metastasis of human prostate primary tumor
lines from orthotopic implants in severe combined immunodeficiency
mice. Clin Cancer Res. 5:711–720. 1999.
|
|
13
|
El-Omar EM, Rabkin CS, Gammon MD, et al:
Increased risk of noncardia gastric cancer associated with
proinflammatory cytokine gene polymorphisms. Gastroenterology.
124:1193–1201. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Faupel-Badger JM, Kidd LC, Albanes D,
Virtamo J, Woodson K and Tangrea JA: Association of IL-10
polymorphisms with prostate cancer risk and grade of disease.
Cancer Causes Control. 19:119–124. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mindiola R, Caulejas D, Nunez-Troconis J,
Araujo M, Delgado M and Mosquera J: Increased number of IL-2, IL-2
receptor and IL-10 positive cells in premalignant lesions of the
cervix. Invest Clin. 49:533–545. 2008.PubMed/NCBI
|
|
16
|
Sharma A, Rajappa M, Saxena A and Sharma
M: Cytokine profile in Indian women with cervical intraepithelial
neoplasia and cancer cervix. Int J Gynecol Cancer. 17:879–885.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stanczuk GA, Sibanda EN, Perrey C, et al:
Cancer of the uterine cervix may be significantly associated with a
gene polymorphism coding for increased IL-10 production. Int J
Cancer. 94:792–794. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ivansson EL, Gustavsson IM, Magnusson JJ,
et al: Variants of chemokine receptor 2 and interleukin 4 receptor,
but not interleukin 10 or Fas ligand, increase risk of cervical
cancer. Int J Cancer. 121:2451–2457. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brower V: Researchers attempting to define
role of cytokines in cancer risk. J Natl Cancer Inst. 97:1175–1177.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Santin AD, Hermonat PL, Ravaggi A, et al:
Interleukin-10 increases Th1 cytokine production and cytotoxic
potential in human papillomavirus-specific CD8(+) cytotoxic T
lymphocytes. J Virol. 74:4729–4737. 2000.PubMed/NCBI
|
|
21
|
Nakagomi H, Pisa P, Pisa EK, et al: Lack
of interleukin-2 (IL-2) expression and selective expression of
IL-10 mRNA in human renal cell carcinoma. Int J Cancer. 63:366–371.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim J, Modlin RL, Moy RL, et al: IL-10
production in cutaneous basal and squamous cell carcinomas. A
mechanism for evading the local T cell immune response. J Immunol.
155:2240–2247. 1995.PubMed/NCBI
|
|
23
|
Pisa P, Halapi E, Pisa EK, et al:
Selective expression of inter-leukin 10, interferon gamma, and
granulocyte-macrophage colony-stimulating factor in ovarian cancer
biopsies. Proc Natl Acad Sci USA. 89:7708–7712. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chan SL, Mo FK, Wong CS, et al: A study of
circulating interleukin 10 in prognostication of unresectable
hepatocellular carcinoma. Cancer. 118:3984–3992. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huettner C, Paulus W and Roggendorf W:
Messenger RNA expression of the immunosuppressive cytokine IL-10 in
human gliomas. Am J Pathol. 146:317–322. 1995.PubMed/NCBI
|
|
26
|
Kruger-Krasagakes S, Krasagakis K, Garbe
C, et al: Expression of interleukin 10 in human melanoma. Br J
Cancer. 70:1182–1185. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
The 1988 Bethesda System for reporting
cervical/vaginal cytological diagnoses. National Cancer Institute
Workshop. JAMA. 262:931–934. 1989. View Article : Google Scholar
|
|
28
|
Clerici M, Merola M, Ferrario E, et al:
Cytokine production patterns in cervical intraepithelial neoplasia:
association with human papillomavirus infection. J Natl Cancer
Inst. 89:245–250. 1997. View Article : Google Scholar
|
|
29
|
Jacobs N, Giannini SL, Doyen J, et al:
Inverse modulation of IL-10 and IL-12 in the blood of women with
preneoplastic lesions of the uterine cervix. Clin Exp Immunol.
111:219–224. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mota F, Rayment N, Chong S, Singer A and
Chain B: The antigen-presenting environment in normal and human
papillomavirus (HPV)-related premalignant cervical epithelium. Clin
Exp Immunol. 116:33–40. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Syrjanen S, Naud P, Sarian L, et al:
Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated
in high-grade CIN but not associated with high-risk human
papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or
incident CIN in the LAMS cohort. Virchows Arch. 455:505–515. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bhairavabhotla RK, Verm V, Tongaonkar H,
Shastri S, Dinshaw K and Chiplunkar S: Role of IL-10 in immune
suppression in cervical cancer. Indian J Biochem Biophys.
44:350–356. 2007.PubMed/NCBI
|
|
33
|
Bermudez-Morales VH, Gutierrez LX,
Alcocer-Gonzalez JM, Burguete A and Madrid-Marina V: Correlation
between IL-10 gene expression and HPV infection in cervical cancer:
a mechanism for immune response escape. Cancer Invest.
26:1037–1043. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bermudez-Morales VH, Peralta-Zaragoza O,
Alcocer-Gonzalez JM, Moreno J and Madrid-Marina V: IL-10 expression
is regulated by HPV E2 protein in cervical cancer cells. Mol Med
Rep. 4:369–375. 2011.PubMed/NCBI
|
|
35
|
Azar KK, Tani M, Yasuda H, Sakai A, Inoue
M and Sasagawa T: Increased secretion patterns of interleukin-10
and tumor necrosis factor-alpha in cervical squamous
intraepithelial lesions. Hum Pathol. 35:1376–1384. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bolpetti A, Silva JS, Villa LL and Lepique
AP: Interleukin-10 production by tumor infiltrating macrophages
plays a role in human papillomavirus 16 tumor growth. BMC Immunol.
11:272010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Woodworth CD, Lichti U, Simpson S, Evans
CH and DiPaolo JA: Leukoregulin and gamma-interferon inhibit human
papillomavirus type 16 gene transcription in human
papillomavirus-immortalized human cervical cells. Cancer Res.
52:456–463. 1992.
|
|
38
|
Madrigal M, Janicek MF, Sevin BU, et al:
In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical
carcinoma. Gynecol Oncol. 64:18–25. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Vinuselvi P, AbiramiVeena R, Vani V and
Prasad S: YING YANG Effect of IL-10 in the incidence of cervical
cancer. Advanced Biotech. 26–29. 2008.
|
|
40
|
Zhou J, Sun XY, Stenzel DJ and Frazer IH:
Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in
epithelial cells is sufficient for assembly of HPV virion-like
particles. Virology. 185:251–257. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Frazer IH: Prevention of cervical cancer
through papillomavirus vaccination. Nat Rev Immunol. 4:46–54. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Leggatt GR and Frazer IH: HPV vaccines:
the beginning of the end for cervical cancer. Curr Opin Immunol.
19:232–238. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lin CT, Tsai YC, He L, et al: A DNA
vaccine encoding a codon-optimized human papillomavirus type 16 E6
gene enhances CTL response and anti-tumor activity. J Biomed Sci.
13:481–488. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang YT, Li W, Liu Q, Guan X and Hu J:
Dendritic cells treated with HPV16mE7 in a three-dimensional model
promote the secretion of IL-12p70 and IFN-γ. Exp Mol Pathol.
91:325–330. 2011.PubMed/NCBI
|
|
45
|
Yoon BS, Kim YT, Kim JW, Kim SH, Kim JH
and Kim SW: Expression of human leukocyte antigen-G and its
correlation with interleukin-10 expression in cervical carcinoma.
Int J Gynaecol Obstet. 98:48–53. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Moreau P, Adrian-Cabestre F, Menier C, et
al: IL-10 selectively induces HLA-G expression in human
trophoblasts and monocytes. Int Immunol. 11:803–811. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Rodriguez JA, Galeano L, Palacios DM, et
al: Altered HLA class I and HLA-G expression is associated with
IL-10 expression in patients with cervical cancer. Pathobiology.
79:72–83. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Urosevic M, Kurrer MO, Kamarashev J, et
al: Human leukocyte antigen G up-regulation in lung cancer
associates with high-grade histology, human leukocyte antigen class
I loss and interleukin-10 production. Am J Pathol. 159:817–824.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Rouas-Freiss N, Marchal RE, Kirszenbaum M,
Dausset J and Carosella ED: The alpha1 domain of HLA-G1 and HLA-G2
inhibits cytotoxicity induced by natural killer cells: is HLA-G the
public ligand for natural killer cell inhibitory receptors? Proc
Natl Acad Sci USA. 94:5249–5254. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Riteau B, Rouas-Freiss N, Menier C, Paul
P, Dausset J and Carosella ED: HLA-G2, -G3, and -G4 isoforms
expressed as nonmature cell surface glycoproteins inhibit NK and
antigen-specific CTL cytolysis. J Immunol. 166:5018–5026. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Dong DD, Yang H, Li K, et al: Human
leukocyte antigen-G (HLA-G) expression in cervical lesions:
association with cancer progression, HPV 16/18 infection, and host
immune response. Reprod Sci. 17:718–723. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Shrestha S, Wang C, Aissani B, Wilson CM,
Tang J and Kaslow RA: Interleukin-10 gene (IL10) polymorphisms and
human papillomavirus clearance among immunosuppressed adolescents.
Cancer Epidemiol Biomarkers Prev. 16:1626–1632. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Matsumoto K, Oki A, Satoh T, et al:
Interleukin-10 -1082 gene polymorphism and susceptibility to
cervical cancer among Japanese women. Jpn J Clin Oncol.
40:1113–1116. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Roh JW, Kim MH, Seo SS, et al:
Interleukin-10 promoter polymorphisms and cervical cancer risk in
Korean women. Cancer Lett. 184:57–63. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Singh H, Jain M, Sachan R and Mittal B:
Association of TNFA (-308G>A) and IL-10 (-819C>T) promoter
polymorphisms with risk of cervical cancer. Int J Gynecol Cancer.
19:1190–1194. 2009.
|
|
56
|
Szoke K, Szalmas A, Szladek G, et al:
IL-10 promoter nt -1082A/G polymorphism and human papillomavirus
infection in cytologic abnormalities of the uterine cervix. J
Interferon Cytokine Res. 24:245–251. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Shekari M, Kordi-Tamandani DM, Malekzadeh
K, Sobti RC, Karimi S and Suri V: Effect of anti-inflammatory
(IL-4, IL-10) cytokine genes in relation to risk of cervical
carcinoma. Am J Clin Oncol. 35:514–519. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Kurte M, López M, Aguirre A, et al: A
synthetic peptide homologous to functional domain of human IL-10
down-regulates expression of MHC class I and transporter associated
with antigen processing 1/2 in human melanoma cells. J Immunol.
173:1731–1737. 2004. View Article : Google Scholar
|
|
59
|
Farzaneh F, Roberts S, Mandal D, et al:
The IL-10 -1082G polymorphism is associated with clearance of HPV
infection. BJOG. 113:961–964. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
de Waal Malefyt R, Haanen J, Spits H, et
al: Interleukin 10 (IL-10) and viral IL-10 strongly reduce
antigen-specific human T cell proliferation by diminishing the
antigen-presenting capacity of monocytes via downregulation of
class II major histocompatibility complex expression. J Exp Med.
174:915–924. 1991.
|
|
61
|
Fiorentino DF, Zlotnik A, Vieira P, et al:
IL-10 acts on the antigen-presenting cell to inhibit cytokine
production by Th1 cells. J Immunol. 146:3444–3451. 1991.PubMed/NCBI
|
|
62
|
de Waal Malefyt R, Yssel H and de Vries
JE: Direct effects of IL-10 on subsets of human CD4+T
cell clones and resting T cells. Specific inhibition of IL-2
production and proliferation. J Immunol. 150:4754–4765.
1993.PubMed/NCBI
|
|
63
|
Taga K, Mostowski H and Tosato G: Human
interleukin-10 can directly inhibit T-cell growth. Blood.
81:2964–2971. 1993.PubMed/NCBI
|
